Novartis Bioventures Ltd Insider Trading $YMTX YUMANITY THERAPEUTICS, INC.
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in YUMANITY THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 1,873,791 shares
Current Value: $27,882,010
Latest Transaction: Feb 17 2016
$YMTX Market Capitalization: $367.66M
$YMTX Previous Close: $14.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in YUMANITY THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 1,944,315 | 0 | 0 | |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 8.00 | 375,000 | 3,000,000 | 1,873,791 | 1.5 M to 1.9 M (+25.02 %) |
| Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 1,498,791 | 0 | 1,498,791 | 0 to 1.5 M |
Page: 1